An in silico model for HIF-α regulation and hypoxia response in tumor cells

Biotechnology and Bioengineering

Volumn 97, Issue 3, 2007, Pages 588-600

  Yucel, Meryem A ^a   Kurnaz, Isil Aksan ^b,c  

^a BOGAZICI UNIVERSITY   (Turkey)

^b YEDITEPE UNIVERSITY   (Turkey)

^c NONE   (Turkey)

Author keywords

Angiogenesis; GEPASI; HIF; Hypoxia; Kinetic modeling; Oxygen sensing

Indexed keywords

ANGIOGENESIS; GEPASI; HYPOXIA; KINETIC MODELING; OXYGEN SENSING;

BLOOD VESSELS; CELL CULTURE; DRUG PRODUCTS; ENZYMES; TUMORS;

BIOMEDICAL ENGINEERING;

ASPARAGINYL HYDROXYLASE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; PROTEASOME; UNCLASSIFIED DRUG; VASCULOTROPIN;

ARTICLE; COMPUTER MODEL; CONTROLLED STUDY; HYPOXIA; MATHEMATICAL ANALYSIS; NONHUMAN; TRANSPORT KINETICS; TUMOR CELL;

ANOXIA; COMPUTATIONAL BIOLOGY; COMPUTER SIMULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MODELS, BIOLOGICAL; TUMOR CELLS, CULTURED;

EID: 34249803191     PISSN: 00063592     EISSN: 10970290     Source Type: Journal    
DOI: 10.1002/bit.21247     Document Type: Article

References (52)

1. Acker T, Acker H. 2004. Cellular oxygen sensing need in CNS function: Physiological and pathological implications. J Exp Biol 207:3171-3188.
2. Aksan Kurnaz I. 2004. A kinetic analysis of RSK2 and Elk-1 interaction on the serum response element and implications for cellular engineering. Biotech Bioeng 88:890-900.
3. Alfranca A, Gutierrez MD, Vara A, Aragones J, Vidal F, Landazuri MO. 2002. c-Jun and HIF-1 functionally cooperate in hypoxia-induced gene transcription. Mol Cell Biol 22:12-22.
4. Arany Z, Huang LE, Eckner R, Bhattacharya S, Jiang C, Goldberg MA, Bunn HF, Livingston DM. 1996. An essential role for p300/CBP in the cellular response to hypoxia. Proc Natl Acad Sci USA 93:12969-12973.
5. Atreya PL, Ananthanarayanan VS. 1991. Interaction of prolyl 4-hydroxylase with synthetic peptide substrates. A conformational model for collagen proline hydroxylation. J Biol Chem 266:2852-2858.
6. Bardos JI, Ashcroft M. 2005. Negative and positive regulation of HIF-1: A complex network. BBA 1755:107-120.
7. Berra E, Benizri E, Ginouves A, Volmat V, Roux D, Pouyssegur J. 2003. HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1α in normoxia. EMBO J 22:4082-4090.
8. Blancher C, Moore JW, Robertson N, Harris AL. 2001. Effects of ras and VHL gene mutations on HIF-1α, HIF-2α and VEGF expression and their regulation by the PI3′-K/Akt signaling pathway. Cancer Res 61:7349-7355.
9. Brahimi-Horn C, Berra E, Pouyssegur J. 2001. Hypoxia: Tumor's gateway to progression along the angiogenic pathway. Trends in Cell Biol 11:S32-S36.
10. Buscaglia M, Schuler B, Lapidus LJ, Eaton WA, Hofrichter J. 2003. Kinetics of intramolecular contact formation in a denatured protein. J Mol Biol 332:9-12.
11. Catimel B, Teh T, Fontes MRM, Jennings IG, Jans DA, Howlett GJ, Nice FC, Kobe B. 2001. Biophysical characterization of interactions involving importin-α during nuclear import. J Biol Chem 276:34189-34198.
12. Chan DA, Sutphin PD, Yen SE, Giaccia AJ. 2005. Coordinate regulation of the oxygen-dependent degradation domains of hypoxia-inducible factor 1 alpha. Mol Cell Biol 25:6415-6426.
13. Chapman-Smith A, Lutwyche JK, Whitelaw ML. 2004. Contribution of the Per/Arnt/Sim PAS domains to DNA binding by the basic helix loop helix PAS transcriptional regulators. J Biol Chem 279:5353-5362.
14. Cooper CE, Delpy DT, Nemoto EM. 1998. The relationship of oxygen delivery to absolute hemoglobin oxygenation and mitochondrial cytochrome oxidase redox state in the adult brain: A near-infrared spectroscopy study. Biochem J 332:627-632.
15. Emir UE, Aksan Kurnaz I. 2003. An integrated model for melanocyte-specific gene expression and melanogenesis. Signal Trans 3:209-217.
16. Erbel PJA, Card PB, Karakuzu O, Bruick RK, Gardner KH. 2003. Structural basis for PAS domain heterodimerization in the basic helix-loop-helix-PAS transcription factor hypoxia-inducible-factor. Biophysics 100: 15504-15509.
17. Frieboes HB, Zheng X, Sun C-H, Tromberg B, Gatenby R, Cristini V. 2006. An integrated computational/experimental model of tumor invasion. Cancer Res 66:1597-1604.
18. Keminer O, Siebrasse JP, Zerf K, Peters R. 1999. Optical recording of signal-mediated protein transport through single nuclear pore complexes. Proc Natl Acad Sci USA 96:11842-11847.
19. Koivunen P, Hirsila M, Gunzler V, Kivirikko KI, Myllyharju J. 2004. Catalytic properties of the asparaginyl hydroxylase (FIH) in the oxygen sensing pathway are distinct from those of its prolyl 4-hydroxylases. J Biol Chem 279:9899-9904.
20. Kukkola L, Koivunen P, Pakkanen O, Page AP, Myllyharju J. 2004. Collagen prolyl 4-hydroxylase tetramers and dimers show identical decreases in Km values for peptide substrates with increasing chain length: Mutation of one of the two catalytic sites in the tetramer inactivates the enzyme by more than half. J Biol Chem 279:18656-18661.
21. Kundu S, Premer SA, Hoy JA, Trent JT3rd, Hargrove MS. 2003. Direct measurement if equilibrium constants for high-affinity hemoglobins. Biophys J 84:3931-3940.
22. Kunz M, Ibrahim SM. 2003. Molecular responses to hypoxia in tumor cells. Mol Cancer 2:23.
23. Lee M, Hwang J-T, Lee H-J, Jung S-N, Kang I, Chi S-G, Kim S-S, Ha J. 2003. AMP-activated protein kinase activity is critical for HIF-1 transcriptional activity and its target gene expression under hypoxic conditions in DU145 cells. J Biol Chem 278:39653-39661.
24. Lee YM, Kim S-H, Kim H-S, Son M-J, Nakajima H, Kwon HJ, Kim K-W. 2003. Inhibition of hypoxia-induced angiogenesis by FK228, a specific histone deacetylase inhibitor, via suppression of HIF-1α activity. BBRC 300:241-246.
25. Liebl U, Bouzhir-Sima L, Négrerie M, Marden JL, Vos MH. 2002. Ultrafast ligand rebinding in the heme domain of the oxygen sensors FixL and Dos: General regulatory implications for heme-based sensors. Biophysics 99:12771-12776.
26. Linke S, Stojkoski C, Kewley RJ, Booker GW, Whitelaw ML, Peet DJ. 2004. Substrate requirements of the oxygen-sensing asparaginyl hydroxylase factor-inhibiting hypoxia-inducible factor. J Biol Chem 279:14391-14397.
27. Mac Cabhann F, Yang MT, Popel AS. 2005. Monte Carlo simulations of VEGF binding to cell surface receptors in vitro. BBA 1746:93-107.
28. Maggelakis S. 2004. Modeling the role of angiogenesis in epidermal wound healing. Discrete and Contin Dynam Syst-Series B 4:267-273.
29. Mahon PC, Hirota K, Semenza GL. 2001. FIH-1: A novel protein that interacts with HIF-1alpha and VHL to mediate repression of HIF-1 transcriptional activity. Genes Dev 15:2675-2686.
30. Marmorstein R. 2001. Structure and function of histone acetyl transferases. Cell Mol Life Sci 58:693-703.
31. Mateo J, Garcia-Lecea M, Cadenas S, Hernandez C, Moncada S. 2003. Regulation of HIF-1alpha by nitric oxide through mitochondria-dependent and -independent pathways. Biochem J 376:537-544.
32. Maxwell PH, Ratcliffe PJ. 2002. Oxygen sensing and angiogenesis. Semin Cell Dev Biol 13:29-37.
33. Mendes P. 1993. GEPASI: A software package for modelling the dynamics, steady states and control of biochemical and other systems. Comput Appl Biosci 9:563-571.
34. Mendes P. 1997. Biochemistry by numbers: Simulation of biochemical pathways with Gepasi 3. Trends Biochem Sci 22:361-363.
35. Mendes P, Kell DB. 1998. Non-linear optimization of biochemical pathways: Applications to metabolic engineering and parameter estimation. Bioinformatics 14:869-883.
36. Metzen E, Berchner-Pfannschmidt U, Stengel P, Marxsen JH, Stolze I, Klinger M, Huang WQ, Wotzlaw C, Hellwig-Burgel T, Jelkmann W, Acker H, Fandrey J. 2003. Intracellular localization of human HIF-1α? hydroxylases: Implications for oxygen sensing. J Cell Sci 116:1319-1326.
37. Miciels C, Minet E, Michel G, Mottet D, Piret J-P, Raes M. 2001. HIF-1 and AP-1 cooperate to increase gene expression in hypoxia: Role of MAP kinases. IUBMB Life 52:49-53.
38. Oney I, Aksan Kurnaz I, Kurnaz ML. 2005. Cytoplasmic-to-nuclear volume ratio affects AP-1 complex formation as an indicator of cell cycle responsiveness. FEBS Lett 579:433-440.
39. Park C, Raines RT. 2003. Catalysis by ribonuclease A is limited by the rate of substrate association. Biochemisty 42:3509-3518.
40. Rabut G, Ellenberg J. 2001. Nucleocytoplasmic transport: Diffusion channel or phase transition? Curr Biol 11:R551-R554.
41. Ribbeck K, Görlich D. 2001. Kinetic analysis of translocation through nuclear membrane pore complexes. EMBO J 20:1320-1330.
42. Richard DE, Berra E, Pouyssegur J. 1999. Angiogenesis: How a tumor adapts to hypoxia. Biochem Biophys Res Commun 266:718-722.
43. Rosen LS. 2005. VEGF-targeted therapy: Therapeutic potential and recent advances. Oncologist 10:382-391.
44. Rouet V, Hamma-Kourbali Y, Petit E, Panagopoulou P, Katsoris P, Barritault D, Caruelle JP, Courty J. 2005. A synthetic glycosaminoglycan mimetic binds vascular endothelial growth factor and modulates angiogenesis. J Biol Chem 280:32792-32800.
45. Seet BT, McCaughan CA, Handel TM, Mercer A, Brunetti C, McFadden G, Fleming SB. 2003. Analysis of an orf virus chemokine-binding protein: Shifting ligand specificities among a family of poxvirus viroceptors. Proc Natl Acad Sci USA 100:15137-15142.
46. Stolze IP, Tian Y-M, Appelhoff RJ, Turley H, Wykoff CC, Gleadle JM, Ratcliffe PJ. 2004. Genetic analysis of the role of the asparaginyl hydroxylase factor inhibiting HIF in regulating HIF transcriptional target genes. J Biol Chem 279:42719-42725.
47. Thompson PR, Kurooka H, Nakatani Y, Cole PA. 2001. Transcriptional Coactivator Protein p300. J Biol Chem 276:33721-33729.
48. 2+ increases. Cell Cale 36:187-199.
49. Tuckerman JR, Zhao Y, Hewitson KS, Tian YM, Pugh CW, Ratcliffe PJ, Mole DR. 2004. Determination and comparison of specific activity of the HIF-prolyl hydroxylases. FEBS Lett 576:145-150.
50. Wright G, Higgin JJ, Raines RT, Steenbergen C, Murphy E. 2003. Activation of the prolyl hydroxylase oxygen-sensor results in induction of GLUT1, Heme Oxygenase-1 and Nitric-oxide synthase proteins and confers protection from metabolic inhibition to cardiomyocytes. J Biol Chem 278:20235-20239.
51. Zheng X, Wise SM, Cristini V. 2005. Nonlinear simulation of tumor necrosis, neo-vascularization and tissue invasion via an adaptive finite-element/level-set method. Bull Math Biol 67:211-259.
52. Zheng X, Ruas JL, Cao R, Salomons FA, Cao Y, Poellinger L, Pereira T. 2006. Cell-type-specific regulation of degradation of HIF-1alpha: Role of subcellular compartmentalization. Mol Cell Biol 26:4628-4641.